Quadrant Future Tek IPO receives overwhelming response, closes Thursday with price band of ₹275-290, funds for long-term ...

The issue received bids of 9,18,47,850 shares against the offered 57,99,999 equity shares, at a price band of ₹275-290, ...

Maze Therapeutics has submitted its pitch for an initial public offering after disclosing a $115 million Series D, forging a ...

The issue, which has a price band set between ₹275-290 per share for its initial offering, is set to open for public ...

The favourable macro factors call for a positive outlook, while there are also a few unexpected regulations to be cautious ...

The Grey Market Premium (GMP) for Quadrant Future Tek's IPO is currently Rs 210 as of January 7, 2024, at 7:00 AM. With the ...

Spheria Emerging Companies (ASX:SEC) will continue as a listed investment company after a conditional proposal to exchange ...

A day before the IPO opening, Quadrant Future Tek has garnered ₹130.5 crore from anchor investors. Foreign and Domestic ...

Quadrant Future Tek IPO offers shares at ₹275-290, with funds raised for specialty cable division, interlocking system, and ...

India-based drug manufacturer Anthem Biosciences has its sights on going public with an IPO that could raise 34 billion ...

Quadrant Future Tek has raised Rs 131 crore from anchor investors, with notable allocations from Bengal Finance and Shine ...

Quadrant Future Tek on Monday said it has raised over Rs 130 crore from anchor investors a day before its initial share sale ...